• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障功能障碍与阿尔茨海默病发病机制。

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.

机构信息

Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.

出版信息

Int J Mol Sci. 2017 Sep 13;18(9):1965. doi: 10.3390/ijms18091965.

DOI:10.3390/ijms18091965
PMID:28902142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5618614/
Abstract

Brain capillary endothelial cells form the blood-brain barrier (BBB), which is covered with basement membranes and is also surrounded by pericytes and astrocyte end-feet in the neurovascular unit. The BBB tightly regulates the molecular exchange between the blood flow and brain parenchyma, thereby regulating the homeostasis of the central nervous system (CNS). Thus, dysfunction of the BBB is likely involved in the pathogenesis of several neurological diseases, including Alzheimer's disease (AD). While amyloid-β (Aβ) deposition and neurofibrillary tangle formation in the brain are central pathological hallmarks in AD, cerebrovascular lesions and BBB alteration have also been shown to frequently coexist. Although further clinical studies should clarify whether BBB disruption is a specific feature of AD pathogenesis, increasing evidence indicates that each component of the neurovascular unit is significantly affected in the presence of AD-related pathologies in animal models and human patients. Conversely, since some portions of Aβ are eliminated along the neurovascular unit and across the BBB, disturbing the pathways may result in exacerbated Aβ accumulation in the brain. Thus, current evidence suggests that BBB dysfunction may causatively and consequently contribute to AD pathogenesis, forming a vicious cycle between brain Aβ accumulation and neurovascular unit impairments during disease progression.

摘要

脑毛细血管内皮细胞形成血脑屏障(BBB),其被基底膜覆盖,同时也被神经血管单元中的周细胞和星形胶质细胞终足环绕。BBB 严格调控血流与脑组织间的分子交换,从而调节中枢神经系统(CNS)的内稳态。因此,BBB 功能障碍可能与包括阿尔茨海默病(AD)在内的多种神经退行性疾病的发病机制有关。虽然脑内淀粉样蛋白-β(Aβ)沉积和神经纤维缠结是 AD 的核心病理标志,但脑血管病变和 BBB 改变也已被证明常同时存在。尽管进一步的临床研究尚需阐明 BBB 破坏是否是 AD 发病机制的一个特定特征,但越来越多的证据表明,在动物模型和人类患者的 AD 相关病变中,神经血管单元的每个组成部分都受到显著影响。相反,由于 Aβ 的某些部分沿着神经血管单元和 BBB 被清除,干扰这些途径可能导致 Aβ 在脑中的积累加剧。因此,目前的证据表明,BBB 功能障碍可能是 AD 发病机制的原因和结果,在疾病进展过程中形成了脑内 Aβ 积累与神经血管单元损伤之间的恶性循环。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/de0842f0f2ec/ijms-18-01965-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/b394dd93d9f7/ijms-18-01965-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/a00eb33b1d7c/ijms-18-01965-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/de0842f0f2ec/ijms-18-01965-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/b394dd93d9f7/ijms-18-01965-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/a00eb33b1d7c/ijms-18-01965-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305d/5618614/de0842f0f2ec/ijms-18-01965-g003.jpg

相似文献

1
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.血脑屏障功能障碍与阿尔茨海默病发病机制。
Int J Mol Sci. 2017 Sep 13;18(9):1965. doi: 10.3390/ijms18091965.
2
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.阿尔茨海默病中的神经血管机制与血脑屏障紊乱
Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25.
3
Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.阿尔茨海默病中血脑屏障功能障碍:来自人体研究的证据。
Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12782. doi: 10.1111/nan.12782. Epub 2022 Feb 2.
4
Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.脑淀粉样血管病和阿尔茨海默病中的内皮线粒体功能障碍
J Alzheimers Dis. 2019;72(4):1019-1039. doi: 10.3233/JAD-190357.
5
Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.阿尔茨海默病中β-淀粉样蛋白与周细胞的相互作用。
Front Biosci (Landmark Ed). 2024 Apr 2;29(4):136. doi: 10.31083/j.fbl2904136.
6
In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.在血脑屏障细胞水平上对低密度脂蛋白受体相关蛋白1(LRP1)作用的体外鉴别:聚焦于脑毛细血管内皮细胞和脑周细胞。
Brain Res. 2015 Jan 12;1594:15-26. doi: 10.1016/j.brainres.2014.10.047. Epub 2014 Oct 31.
7
ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.ABCG2在伴有脑淀粉样血管病的阿尔茨海默病大脑中上调,可能作为β淀粉样蛋白(1-40)肽通过血脑屏障的守门蛋白。
J Neurosci. 2009 Apr 29;29(17):5463-75. doi: 10.1523/JNEUROSCI.5103-08.2009.
8
Annexin A1 restores Aβ -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway.膜联蛋白A1通过抑制RhoA-ROCK信号通路恢复β淀粉样蛋白诱导的血脑屏障破坏。
Aging Cell. 2017 Feb;16(1):149-161. doi: 10.1111/acel.12530. Epub 2016 Sep 16.
9
Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.阿尔茨海默病进展过程中皮质内皮紧密连接蛋白的选择性丢失。
Brain. 2019 Apr 1;142(4):1077-1092. doi: 10.1093/brain/awz011.
10
HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.高迁移率族蛋白B1(HMGB1)和凝血酶介导血脑屏障功能障碍,作为神经炎症和阿尔茨海默病向神经退行性变发展的生物标志物。
J Neuroinflammation. 2016 Aug 24;13(1):194. doi: 10.1186/s12974-016-0670-z.

引用本文的文献

1
Real-Time, Continuous Monitoring of Tissue Chips as an Emerging Opportunity for Biosensing.组织芯片的实时连续监测——生物传感的新机遇
Sensors (Basel). 2025 Aug 19;25(16):5153. doi: 10.3390/s25165153.
2
Erythrocyte Load in Cerebrospinal Fluid Linked with Hippocampal Atrophy in Alzheimer's Disease.脑脊液中的红细胞负荷与阿尔茨海默病的海马萎缩相关
J Clin Med. 2025 Jul 1;14(13):4670. doi: 10.3390/jcm14134670.
3
Circadian influences on central nervous system barriers and the glymphatic system.昼夜节律对中枢神经系统屏障和类淋巴系统的影响。

本文引用的文献

1
Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis.阿尔茨海默病、脑血管疾病与心血管风险之间的病理生理关系:综述与整合
Alzheimers Dement (Amst). 2017 Feb 9;7:69-87. doi: 10.1016/j.dadm.2017.01.005. eCollection 2017.
2
The role of peripheral immune cells in the CNS in steady state and disease.外周免疫细胞在中枢神经系统中的稳态和疾病中的作用。
Nat Neurosci. 2017 Feb;20(2):136-144. doi: 10.1038/nn.4475. Epub 2017 Jan 16.
3
Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains.
Front Physiol. 2025 Jun 23;16:1622236. doi: 10.3389/fphys.2025.1622236. eCollection 2025.
4
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases.间充质干细胞衍生的细胞外囊泡:神经退行性疾病的新兴疗法
Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025.
5
A Comprehensive Systematic Review and Meta-Analysis to Unravel the Noise-Dementia Nexus.一项揭示噪音与痴呆症关系的全面系统综述和荟萃分析。
Public Health Rev. 2025 Jun 16;46:1607355. doi: 10.3389/phrs.2025.1607355. eCollection 2025.
6
Acupuncture for neurodegenerative diseases: mechanisms, efficacy, and future research directions.针灸治疗神经退行性疾病:作用机制、疗效及未来研究方向
Am J Transl Res. 2025 May 15;17(5):3703-3717. doi: 10.62347/QFJO6227. eCollection 2025.
7
Dementia from Small Vessel Disease Versus Alzheimer's Disease: Separate Diseases or Distinct Manifestations of Cerebral Capillopathy Due to Blood-Brain Barrier Dysfunction? A Pilot Study.小血管病性痴呆与阿尔茨海默病:是两种独立的疾病,还是血脑屏障功能障碍所致脑毛细血管病的不同表现?一项初步研究。
Int J Mol Sci. 2025 May 23;26(11):5040. doi: 10.3390/ijms26115040.
8
Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and Management.血管功能障碍与神经退行性病变之间的相互作用:分子机制与治疗的新见解
Biomolecules. 2025 May 13;15(5):712. doi: 10.3390/biom15050712.
9
Optimized enrichment of murine blood-brain barrier vessels with a critical focus on network hierarchy in post-collection analysis.优化小鼠血脑屏障血管的富集,重点关注采集后分析中的网络层次结构。
Sci Rep. 2025 May 6;15(1):15778. doi: 10.1038/s41598-025-99364-3.
10
A second act for spironolactone: cognitive benefits in renal dysfunction - a critical review.螺内酯的新作用:对肾功能不全的认知益处——一项批判性综述
Metab Brain Dis. 2025 Apr 29;40(5):194. doi: 10.1007/s11011-025-01623-9.
血管周围水通道蛋白-4 定位与衰老大脑认知功能和阿尔茨海默病的关系。
JAMA Neurol. 2017 Jan 1;74(1):91-99. doi: 10.1001/jamaneurol.2016.4370.
4
2016 Alzheimer's disease facts and figures.2016 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001.
5
The blood-brain barrier in Alzheimer's disease.阿尔茨海默病中的血脑屏障。
Neurobiol Dis. 2017 Nov;107:41-56. doi: 10.1016/j.nbd.2016.07.007. Epub 2016 Jul 15.
6
Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.载脂蛋白E作为阿尔茨海默病的治疗靶点:基础研究与临床证据综述
CNS Drugs. 2016 Sep;30(9):773-89. doi: 10.1007/s40263-016-0361-4.
7
Pericytes of the neurovascular unit: key functions and signaling pathways.神经血管单元的周细胞:关键功能与信号通路
Nat Neurosci. 2016 May 26;19(6):771-83. doi: 10.1038/nn.4288.
8
Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.性别和APOE4对阿尔茨海默病中脑淀粉样血管病的影响。
Acta Neuropathol. 2016 Aug;132(2):225-234. doi: 10.1007/s00401-016-1580-y. Epub 2016 May 14.
9
Vascular basement membranes as pathways for the passage of fluid into and out of the brain.血管基底膜作为液体进出大脑的通道。
Acta Neuropathol. 2016 May;131(5):725-36. doi: 10.1007/s00401-016-1555-z. Epub 2016 Mar 14.
10
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.Aβ40通过泛素-蛋白酶体途径降低血脑屏障处的P-糖蛋白水平。
J Neurosci. 2016 Feb 10;36(6):1930-41. doi: 10.1523/JNEUROSCI.0350-15.2016.